Cancer Genetics, Inc. Increases Access to its Full-Suite of Cancer Diagnostic Services through Agreement with Three Rivers Provider Network
By Italia on January 28 2014
CGI services are now accessible by an additional 15 million individuals in the U.S. RUTHERFORD, NJ (January 28, 2014): Cancer Genetics, Inc. (NASDAQ:CGIX) (“CGI” or the “Company”), an emerging leader in DNA-based diagnostics, today announced the Company executed an agreement with health insurer Three Rivers Provider Network, Inc., one of the largest and fastest-growing preferred provider (“PPO”) […]
Continue ReadingCancer Genetics, Inc. to Present at Two Investor Conferences in January
By Italia on January 8 2014
RUTHERFORD, NJ (January 8, 2014): Cancer Genetics, Inc. (NASDAQ:CGIX) (“CGI” or the “Company”), an emerging leader in DNA-based diagnostics, today announced its CEO Panna Sharma will present at the following investor conferences: 7th Annual OneMedForumSF 2014, January 13-15, 2014 in San Francisco; CGI will present at 10:30 a.m. PT, Tuesday, January 14 Noble Financial’s 10th Annual Equity […]
Continue ReadingCancer Genetics Appoints John Pappajohn Chairman of the Board of Directors
By Italia on January 6 2014
RUTHERFORD, NJ (January 6, 2014): Cancer Genetics, Inc. (NASDAQ: CGIX) (“CGI” or the “Company”), a DNA-based diagnostics company, today announced that its board of directors appointed John Pappajohn as its new Chairman, effective January 6, 2014. Mr. Pappajohn is a recognized business leader and a pioneer in the venture capital industry. He has been involved in over 100 start-up companies, over 50 IPOs, and has served as […]
Continue Reading